Ambrx gets orphan drug designation for gastric cancer treatment ARX788

With the orphan drug designation for ARX788, biopharmaceutical company Ambrx gets to enjoy benefits such as exemption towards tax credits for qualified clinical trials and FDA prescription drug user fees. Anastasiia Ostapovych/Unsplash